Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the site footer, and older notices including 'Revision: v3.4.1' and the funding lapse notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page now displays a government funding lapse notice at the top, informing users about potential processing delays and directing to official status sources. The revision tag has changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check27 days agoChange DetectedThe page now includes a 'Show glossary' option and adds the 'Last Update Submitted that Met QC Criteria' metadata with revision 'v3.4.0'. It removes the older 'Last Update Submitted that met QC Criteria' field, the 'No FEAR Act data' item, and the previous revision 'v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedAn administrative revision note was added: Revision: v3.3.4, replacing the previous Revision: v3.3.3. There is no indication that study content, eligibility criteria, or results were changed.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed; the previous Revision: v3.3.2 label is no longer shown.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; no substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.